Vraylar (cariprazine) is not a controlled drug or substance.

Vraylar is an atypical antipsychotic used in the treatment of schizophrenia, in the acute treatment of manic or mixed episodes associated with bipolar I disorder, in the treatment of depressive episodes associated with bipolar I disorder, and as an add-on to antidepressants in the treatment of major depressive disorder.

Why might people think that Vraylar is a controlled drug?

Vraylar use may decrease substance abuse in patients with bipolar I disorder. Substance use disorders are sometimes treated with controlled drugs, such as methadone, and are commonly associated with bipolar I disorder and schizophrenia.

Certain drugs are classed as controlled substances

Some drugs, substances or chemicals are classified as controlled substances. These agents are more closely regulated and fall into one of five categories or schedules. Drugs with a high potential for abuse and potential to create severe dependence are listed as Schedule I drugs and those with the least potential for abuse are listed as Schedule V drugs.